September 21 (SeeNews) - Bulgaria's animal and human health and nutraceuticals company Huvepharma aims to expand the capacity of its solar plant to 190 MW by 2023 from 25 MW in 2021, CEO Kiril Domuschiev said.
The plant, which was built as part of the company’s sustainable business practices, should eventually reach a capacity of 300 MW, Domuschiev said in a press release on Tuesday.
You can download the 2024 Renewable energy in Southeast Europe report here
According to an earlier statement, the company is investing 180 million euro ($178.3 million) in the project, which is expected to make Huvepharma self-sufficient in its energy needs.
Aiming to become carbon neutral by 2030, Huvepharma has already installed wastewater treatment plants, biomass plants and air filtration systems.
Headquartered in Sofia, Huvepharma is focused on developing, manufacturing and marketing human health and animal health and nutrition products. Its manufacturing subsidiary, Biovet, is headquartered in Peshtera, and has independent manufacturing units in several other locations.
($ = 1.0093 euro)